125290-87-1 Usage
Uses
Used in Pharmaceutical Industry:
3-(boc-aMinoMethyl)-3-Methyl-pyrrolidine is used as a building block in organic synthesis for its ability to contribute to the creation of complex molecular structures in pharmaceutical compounds. The Boc-protected amine group ensures that the amine functionality remains intact during various chemical reactions, which is crucial for the synthesis of specific drug molecules.
Used in Peptide Synthesis:
In the field of peptide synthesis, 3-(boc-aMinoMethyl)-3-Methyl-pyrrolidine serves as a key component, providing a protected amine group that is essential for the formation of peptide bonds. This protection allows for the controlled synthesis of peptides, ensuring the desired product is obtained without unwanted side reactions.
Used in Asymmetric Synthesis:
3-(boc-aMinoMethyl)-3-Methyl-pyrrolidine is utilized as a chiral auxiliary in asymmetric synthesis, enabling chemists to produce enantiomerically pure products. This is particularly important in the pharmaceutical industry, where the desired biological activity is often associated with a specific enantiomer, and the undesired enantiomer may have adverse effects.
Used in Drug Discovery and Development:
3-(boc-aMinoMethyl)-3-Methyl-pyrrolidine's potential biological and pharmacological activities make it a valuable asset in drug discovery and development. Researchers can explore its properties to identify new therapeutic agents or to improve the efficacy and selectivity of existing drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 125290-87-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,2,9 and 0 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 125290-87:
(8*1)+(7*2)+(6*5)+(5*2)+(4*9)+(3*0)+(2*8)+(1*7)=121
121 % 10 = 1
So 125290-87-1 is a valid CAS Registry Number.
125290-87-1Relevant articles and documents
ANTIBACTERIAL AGENTS
-
Page/Page column 177-178, (2010/02/15)
Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.
